Status: Recruiting
Spanish Series of Patients Treated With the Radionuclide Lutetium177
This study aims to pool the clinical experience of Spanish centers treating patients with 177Lu-DOTATATE to evaluate the efficacy, tolerance, and safety of the drug in routine clinical practice and to learn about the profiles of patients and tumors treated and the results in each type of patient and tumor.
Participants needed: 5,000
Trial details
Age: 18-100Biological sex: AllType: ObservationalSponsor: Sociedad Española de Medicina Nuclear e Imagen MolecularUpdated: Dec 23, 2022Locations: 20
Eligibility criteria
Written informed consent must be obtained prior to any data collection. [+2]
None